Skip to main content

RBF Capital, LLC

Position in AVIR — Atea Pharmaceuticals, Inc.

CIK 1134621 RENO, NV

Position in AVIR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$139,500
-$21,900 QoQ
Shares Held
30,000
0.0% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#60
of 125 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RBF Capital, LLC holds $5,245,524 across 20 Biotechnology names. AVIR ranks #16 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVIR

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $139,500 30,000
2026-03-31 $161,400 30,000
2025-12-31 $107,100 30,000
2025-09-30 $87,000 30,000
2025-06-30 $108,000 30,000
2025-03-31 $134,337 44,929
2024-12-31 $184,012 54,929
2024-09-30 $497,310 148,451
2024-06-30 $491,372 148,451
2024-03-31 $599,742 148,451
2023-12-31 $464,868 152,416
2023-09-30 $457,248 152,416
2023-06-30 $593,347 158,649
2023-03-31 $720,012 214,929
2022-12-31 $1,289,998 268,191